MONDAY, April 8, 2024 (HealthDay News) — A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says. Eight patients have not had their pancreatic cancer recur for three years after their immuneContinue Reading
MONDAY, April 8, 2024 (HealthDay News) — Pancreatic cancer patients may do better if they receive an immunotherapy drug as well as chemotherapy in preparation for surgery, new research suggests. Pancreatic cancer is one of the toughest to treat. Only 12% of patients live more than five years after diagnosis.Continue Reading
FRIDAY, April 5, 2024 (HealthDay News) — As the world’s population ages, a new report warns that the number of people with cancer could climb 77% by 2050. In the report, published Thursday in the journal CA: A Cancer Journal for Clinicians, researchers from the American Cancer Society found there wereContinue Reading
THURSDAY, April 4, 2024 (HealthDay News) — Cancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows. An estimated 20 million new cancer cases were diagnosed in 2022, and 9.7 million died from cancer around the globe, theContinue Reading
WEDNESDAY, April 3, 2024 (HealthDay News) — Three anti-smoking groups announced Tuesday that they have sued the U.S. government yet again after it missed its latest deadline for enacting a ban on menthol cigarettes. This is the second lawsuit that the plaintiffs — the African American Tobacco Control Leadership Council,Continue Reading
WEDNESDAY, April 3, 2024 (HealthDay News) — Microwaves could offer an alternative to surgery for some people with thyroid cancer, a new study suggests. Microwave ablation, which uses heat to destroy tumors, more effectively targeted thyroid cancers on multiple parts of the gland than surgery did, researchers report April 2Continue Reading
WEDNESDAY, April 3, 2024 (HealthDay News) — More patients these days are taking part in cancer research, a new study finds. At least one in five people with cancer (22%) participate in some form of clinical research, when all types of cancer studies are considered, researchers found. Moreover, enrollment inContinue Reading
WEDNESDAY, April 3, 2024 (HealthDay News) — A new test might allow some women with an aggressive form of breast cancer to skip chemotherapy without harm, researchers say. Women with early-stage triple-negative breast cancer appear to have better survival rates and a lower risk of recurrence if they carry highContinue Reading
THURSDAY, March 28, 2024 (HealthDay News) — Dr. Gary Gibbon didn’t have long to live. A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently destroyed his lungs and caused irreparable damage to his liver. But Gibbon, a 69-year-old resident of Santa Monica, Calif., remainsContinue Reading
MONDAY, March 25, 2024 (HealthDay News) — Men with prostate cancer treated at hospitals participating in a special drug-pricing program were more likely to stick to their therapy than patients elsewhere, new research reveals. The federal 340B Drug Program requires the pharmaceutical industry to discount drugs sold to participating hospitalsContinue Reading